Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
37,365
Sort by:
Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)
US$ 1,700.00
... and innovation in therapeutics. The global blood plasma market is broadly segmented into four types which are Immunoglobulin, Albumin, Factor VIII, Alpha ... : The report provides a comprehensive analysis of the global blood plasma market, segmented into Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others. ...
July 2019
109 pages
Beta-2 Microglobulin Testing Market, 2019-2023: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities
US$ 3,500.00
... disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. ... worldwide. This report presents a detailed analysis of the ß-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ...
July 2019
243 pages
CA Tumor Markers Testing Market, 2019-2023: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities
US$ 3,850.00
... numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The ... report presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ...
July 2019
278 pages
France HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares and Country Segment Forecasts, 2019-2023
US$ 1,850.00
... presents detailed analyses of the AIDS diagnostics market in France. The report provides test volume and sales forecasts forHIV/HIV-1/2/Combo, HIVAg/HIV,NAT,Western Blot, HTLV ...
July 2019
250 pages
Germany HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares and Country Segment Forecasts, 2019-2023
US$ 1,850.00
... presents detailed analyses of the AIDS diagnostics market in Germany. The report provides test volume and sales forecasts forHIV/HIV-1/2/Combo, HIVAg/HIV,NAT,Western Blot, HTLV ...
July 2019
250 pages
PSA Testing Market, 2019-2023: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities
US$ 3,500.00
... disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ... worldwide. This report presents a detailed analysis of the PSA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including ...
July 2019
249 pages
Prostatic Acid Phosphatase (PAP) Testing Market, 2019-2023: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities
US$ 3,500.00
... disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. ... market expansion worldwide. This report presents a detailed analysis of the PAP testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ...
July 2019
242 pages
Occult Blood Testing Market, 2019-2023: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities
US$ 3,500.00
... disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ... worldwide. This report presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ...
July 2019
243 pages
AFP Testing Market, 2019-2023: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities
US$ 3,500.00
... disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ... worldwide. This report presents a detailed analysis of the Alpha-fetoprotein testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ...
July 2019
248 pages
CEA Testing Market, 2019-2023: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities
US$ 3,500.00
... disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ... worldwide. This report presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including ...
July 2019
250 pages
Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing, 2019-2023: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies
US$ 4,850.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
July 2019
495 pages
Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing, 2019-2023: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies
US$ 1,850.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
July 2019
407 pages
Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing, 2019-2023: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies
US$ 1,850.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
July 2019
402 pages
U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing, 2019-2023: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies
US$ 2,450.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
July 2019
430 pages
US Point-of-Care /POC PT and APTT Testing Market, 2019-2023: Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review--Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 2,500.00
... Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers Sales and ... prices. Technology Review Emerging technologies and their applications for POC testing. Comprehensive listings of companies developing or marketing coagulation testing ...
July 2019
337 pages
US Point-of-Care/POC Lipid Testing Market, 2019-2023: Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review--Physician Offices, Emergency Rooms, Ambulatory Care Centers
US$ 2,500.00
... , and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory ... lipid tests by market segment: Physician Offices/Group Practices Emergency Rooms Ambulatory Care Centers Competitive Assessments Assessments of major POC suppliers and emerging market ...
July 2019
305 pages
